Company Information
- Type:
- Company
- Country:
- Japan
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Delisted
- Reason for Delisting:
- Expelled due to failure to communicate progress
- Participant Since
- 29 December 2009 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 30 November 2017
Financial Information
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 30-Nov-2016 | Communication on Progress 2016 | Active |
| 30-Nov-2016 | Communication on Progress 2015 | Active |
| 22-Dec-2014 | Communication on Progress | Active |
| 19-Dec-2014 | Reporting Cycle Adjustment | Not applicable |
| 17-Dec-2013 | Communication on Progress | Active |
| 11-Jan-2013 | Communication on Progress 2012 | Learner |
| 11-Jan-2012 | Communication on Progress | Learner |
| 28-Dec-2011 | Grace Letter | Not applicable |
| 28-Dec-2010 | 2010 Communication on Progress | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.